|
1
|
Yao X, Panichpisal K, Kurtzman N and
Nugent K: Cisplatin nephrotoxicity: A review. Am J Med Sci.
334:115–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coates A, Abraham S, Kaye SB, Sowerbutts
T, Frewin C, Fox RM and Tattersall MH: On the receiving end-patient
perception of the side-effects of cancer chemotherapy. Eur J Cancer
Clin Oncol. 19:203–208. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Decker-Baumann C, Buhl K, Frohmüller S,
von Herbay A, Dueck M and Schlag PM: Reduction of
chemotherapy-induced side-effects by parenteral glutamine
supplementation in patients with metastatic colorectal cancer. Eur
J Cancer. 35:202–207. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mantovani G, Maccio A, Bianchi A, Curreli
L, Ghiani M, Santona MC and Del Giacco GS: Megestrol acetate in
neoplastic anorexia/cachexia: Clinical evaluation and comparison
with cytokine levels in patients with head and neck carcinoma
treated with neoadjuvant chemotherapy. Int J Clin Lab Res.
25:135–141. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bender CM, McDaniel RW, Murphy-Ende K,
Pickett M, Rittenberg CN, Rogers MP, Schneider SM and Schwartz RN:
Chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs.
6:94–102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bosnjak SM, Dimitrijevic J and Djordjevic
F: Cancer and chemotherapy-induced nausea and vomiting: A focus on
olanzapine. Curr Opin Support Palliat Care. 10:180–188. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Metri K, Bhargav H, Chowdhury P and Koka
PS: Ayurveda for chemo-radiotherapy induced side effects in cancer
patients. J Stem Cells. 8:115–129. 2013.PubMed/NCBI
|
|
8
|
Aoyagi T, Terracina KP, Raza A, Matsubara
H and Takabe K: Cancer cachexia, mechanism and treatment. World J
Gastrointest Oncol. 7:17–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fernández-Lucas M, Díaz-Domínguez ME,
Ruiz-Roso G, Raoch V, Teruel-Briones JL and
Quereda-Rodríguez-Navarro C: Anorexia and megestrol acetate:
Treatment versus placebo controlled study. Nefrologia. 34:416–417.
2014.PubMed/NCBI
|
|
10
|
Cuvelier GD, Baker TJ, Peddie EF, Casey
LM, Lambert PJ, Distefano DS, Wardle MG, Mychajlunow BA, Romanick
MA, Dix DB and Wilson BA: A randomized, double-blind,
placebo-controlled clinical trial of megestrol acetate as an
appetite stimulant in children with weight loss due to cancer
and/or cancer therapy. Pediatr Blood Cancer. 61:672–679. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
De Conno F, Martini C, Zecca E, Balzarini
A, Venturino P, Groff L and Caraceni A: Megestrol acetate for
anorexia in patients with far-advanced cancer: A double-blind
controlled clinical trial. Eur J Cancer. 34:1705–1709. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ruiz Garcia V, López-Briz E, Carbonell
Sanchis R, Gonzalvez Perales JL and Bort-Marti S: Megestrol acetate
for treatment of anorexia-cachexia syndrome. Cochrane Database Syst
Rev. 28:CD0043102013.
|
|
13
|
Sung JH, An HS, Jeong JH, Shin S and Song
SY: Megestrol acetate increases the proliferation, migration, and
adipogenic differentiation of adipose-derived stem cells via
glucocorticoid receptor. Stem Cells Transl Med. 4:789–799. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nelson KA, Walsh D and Hussein M: A phase
II study of low-dose megestrol acetate using twice-daily dosing for
anorexia in nonhormonally dependent cancer. Am J Hosp Palliat Care.
19:206–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Votaw ML: Excessive sweating: Unusual side
effect of megestrol acetate therapy. Tenn Med. 90:591997.PubMed/NCBI
|
|
16
|
Woo SM, Choi YK, Kim AJ, Yun YJ, Shin YC,
Cho SG and Ko SG: Sip-jeon-dea-bo-tang, a traditional herbal
medicine, ameliorates cisplatin-induced anorexia via the activation
of JAK1/STAT3-mediated leptin and IL-6 production in the fat tissue
of mice. Mol Med Rep. 13:2967–2972. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi YK, Jung KY, Woo SM, Yun YJ, Jun CY,
Park JH, Shin YC, Cho SG and Ko SG: Effect of Sipjeondaebotang on
cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice.
Mediators Inflamm. 2014:7365632014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ohno T, Yanai M, Ando H, Toyomasu Y, Ogawa
A, Morita H, Ogata K, Mochiki E, Asao T and Kuwano H: Rikkunshito,
a traditional Japanese medicine, suppresses cisplatin-induced
anorexia in humans. Clin Exp Gastroenterol. 4:291–296. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takeda H, Sadakane C, Hattori T, Katsurada
T, Ohkawara T, Nagai K and Asaka M: Rikkunshito, an herbal
medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2
receptor antagonism. Gastroenterology. 134:2004–2013. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song BK, Won JH and Kim S: Historical
Medical Value of Donguibogam. J Pharmacopuncture. 19:16–20. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zee-Cheng RK: Shi-quan-da-bu-tang (ten
significant tonic decoction), SQT. A potent Chinese biological
response modifier in cancer immunotherapy, potentiation and
detoxification of anticancer drugs. Methods Find Exp Clin
Pharmacol. 14:725–736. 1992.PubMed/NCBI
|
|
22
|
Piao JH, Zhang L, Zhang H, Gao TH and Li
XH: Experimental studies on antianimia effect of shengxuesu.
Zhongguo Zhong Yao Za Zh. 28:544–547. 2003.(In Chinese).
|
|
23
|
Sun W, Meng K, Qi C, Yang X, Wang Y, Fan
W, Yan Z, Zhao X and Liu J: Immune-enhancing activity of
polysaccharides isolated from Atractylodis macrocephalae Koidz.
Carbohydr Polym. 126:91–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv Y, Feng X and Zhu B: Study on effect of
Astragalus membranaceus injection on hematopoiesis in anemic mice
with myelosuppression. Zhong Yao Cai. 28:791–793. 2005.(In
Chinese). PubMed/NCBI
|
|
25
|
Zhu X and Zhu B: Effect of Astragalus
membranaceus injection on megakaryocyte hematopoiesis in anemic
mice. Hua Xi Yi Ke Da Xue Xue Bao. 32:590–592. 2001.(In Chinese).
PubMed/NCBI
|
|
26
|
Auyeung KK, Han QB and Ko JK: Astragalus
membranaceus: A review of its protection against inflammation and
gastrointestinal cancers. Am J Chin Med. 44:1–22. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shang X, Pan H, Li M, Miao X and Ding H:
Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and
pharmacology of an important traditional Chinese medicine. J
Ethnopharmacol. 138:1–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rasool S and Sharma B: Taraxacum
officinale: A high value less known medicinal plant. Ann Plant Sci.
3:908–915. 2014.
|
|
29
|
Kirbağ S, Zengin F and Kursat M:
Antimicrobial activities of extracts of some plants. Pak J Bot.
41:2067–2070. 2009.
|
|
30
|
Fang X, Yu MM, Yuen WH, Zee SY and Chang
RC: Immune modulatory effects of Prunella vulgaris L. On
monocytes/macrophages. Int J Mol Med. 16:1109–1116. 2005.PubMed/NCBI
|
|
31
|
FDA K: Safety MOFAD: Guidance on good
manufacturing practices (GMP) for active pharmaceutical
ingredients. 2015.
|
|
32
|
Organization WH: Annex 3 supplementary
guidelines on good manufacturing practices for the manufacture of
herbal medicines. 85–106. 2006.
|
|
33
|
Damia G and D'Incalci M: Mechanisms of
resistance to alkylating agents. Cytotechnology. 27:165–173. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Malhotra V and Perry MC: Classical
chemotherapy: Mechanisms, toxicities and the therapeutic window.
Cancer Biol Ther. 2 4 Suppl 1:S2–S4. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee CS, Ryan EJ and Doherty GA:
Gastro-intestinal toxicity of chemotherapeutics in colorectal
cancer: The role of inflammation. World J Gastroenterol.
20:3751–3761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ohnishi S and Takeda H: Herbal medicines
for the treatment of cancer chemotherapy-induced side effects.
Front Pharmacol. 6:142015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takeda H, Muto S, Nakagawa K, Ohnishi S
and Asaka M: Rikkunshito and ghrelin secretion. Curr Pharm Des.
18:4827–4838. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dixit VD, Schaffer EM, Pyle RS, Collins
GD, Sakthivel SK, Palaniappan R, Lillard JW Jr and Taub DD: Ghrelin
inhibits leptin- and activation-induced proinflammatory cytokine
expression by human monocytes and T cells. J Clin Invest.
114:57–66. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang F, Chen Y, Heiman M and Dimarchi R:
Leptin: Structure, function and biology. Vitam Horm. 71:345–372.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shirazi R, Palsdottir V, Collander J,
Anesten F, Vogel H, Langlet F, Jaschke A, Schürmann A, Prévot V,
Shao R, et al: Glucagon-like peptide 1 receptor induced suppression
of food intake, and body weight is mediated by central IL-1 and
IL-6. Proc Natl Acad Sci USA. 110:pp. 16199–16204. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Buettner C, Pocai A, Muse ED, Etgen AM,
Myers MG Jr and Rossetti L: Critical role of STAT3 in leptin's
metabolic actions. Cell Metab. 4:49–60. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Engineer DR and Garcia JM: Leptin in
anorexia and cachexia syndrome. Int J Pept. 2012:2874572012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Suprasert P, Aue-Aungkul A and Pautad N:
Lack of Relationship of Egg white intake with occurrence of
leukopenia in gynecologic cancer patients during chemotherapy.
Asian Pac J Cancer Prev. 17:1265–1267. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rodgers GM III, Becker PS, Bennett CL,
Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF,
Djulbegovic B, Garst JL, et al: Cancer- and chemotherapy-induced
anemia. J Natl Compr Canc Netw. 6:536–564. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Munoz-Langa J, De Castro J, Gasco P, et
al: Chemotherapy-associated anemia in patients with lung cancer: An
epidemiological, retrospective and multicenter study. Future Oncol.
11:1665–1674. View Article : Google Scholar : PubMed/NCBI
|
